TJBH has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TJBH has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Tengjun Biotechnology's interest expense for the three months ended in Jun. 2023 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.0 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Tengjun Biotechnology's Operating Income for the three months ended in Jun. 2023 was $ -0.4 Mil. Tengjun Biotechnology's Interest Expense for the three months ended in Jun. 2023 was $ 0.0 Mil. Tengjun Biotechnology has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical data trend for Tengjun Biotechnology's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tengjun Biotechnology Annual Data | |||||||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | |||||||||||
Interest Expense | Get a 7-Day Free Trial | -0.02 | -0.02 | -0.02 | -0.01 | - |
Tengjun Biotechnology Quarterly Data | ||||||||||||||||||||
Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Interest Expense | Get a 7-Day Free Trial | - | - | - | - | - |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tengjun Biotechnology (OTCPK:TJBH) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Tengjun Biotechnology's Interest Expense for the three months ended in Jun. 2023 was $0.0 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-0.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was $0.0 Mil.
Tengjun Biotechnology's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as
Tengjun Biotechnology had no long-term debt (1). |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Tengjun Biotechnology Corp has no debt.
Qiuping Lu | director, 10 percent owner, officer: Vice President, Treasurer, CFO | 505 WEST 8TH AVENUE, SUITE 16, MESA AZ 85201 |
Fumin Feng | director, 10 percent owner, officer: Secretary | BLOCK 5, ROOM 2503, WANDA SQUARE, NO.93 JIANGUO ROAD, BEIJING NY 100022 |
Blue Water Restaurant Group, Inc. | 10 percent owner | 7070 E FARRELL RD, SE, SUITE 1019, CALGARY A0 T2H 0T2 |
Nina E. Edstrom | director, 10 percent owner, officer: Sole Officer and Director | C/O THE MAILBOX #5241, P. O. BOX 523882, MIAMI FL 33152 |
Taurus Financial Partners, Llc | 10 percent owner | C/O THE MAILBOX #5241, P. O. BOX 523882, MIAMI FL 33152 |
From GuruFocus
By PRNewswire • 09-21-2023
By PRNewswire • 09-29-2023
By Marketwired • 09-26-2023
By Marketwired • 09-18-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.